Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Bradley Warady to Cadaver

This is a "connection" page, showing publications Bradley Warady has written about Cadaver.

 
Connection Strength
  
 
 
0.380
  
  1. Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF, Warady BA. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation. 2005 Jul 15; 80(1):75-80.
    View in: PubMed
    Score: 0.068
  2. Bryan CF, Harrell KM, Mitchell SI, Warady BA, Aeder MI, Luger AM, Murillo D, Muruve NA, Nelson PW, Shield CF. HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors. Am J Transplant. 2003 Apr; 3(4):459-64.
    View in: PubMed
    Score: 0.058
  3. Schurman SJ, Stablein DM, Perlman SA, Warady BA. Center volume effects in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1999 Jun; 13(5):373-8.
    View in: PubMed
    Score: 0.044
  4. Bryan CF, Harrell K, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation. Transplant Proc. 1993 Dec; 25(6):3060-3.
    View in: PubMed
    Score: 0.030
  5. Bryan CF, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient. Transplant Proc. 1993 Dec; 25(6):3273-4.
    View in: PubMed
    Score: 0.030
  6. Bryan CF, Aeder MI, Helling TS, Hughes J, Luger AM, Nelson PW, Pierce GE, Shield CF, Warady B. Influence of HLA and race on long-term cadaveric renal transplantation. Transplant Proc. 1992 Dec; 24(6):2451-3.
    View in: PubMed
    Score: 0.028
  7. Bryan CF, Wakefield M, Reese JC, Shield CF, Warady BA, Winklhofer FT, Murillo D. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transplant. 2007 Jan-Feb; 21(1):72-9.
    View in: PubMed
    Score: 0.019
  8. Nelson PW, Shield CF, Muruve NA, Murillo D, Warady BA, Aeder MI, Bryan CF. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? Am J Transplant. 2002 Jan; 2(1):94-9.
    View in: PubMed
    Score: 0.013
  9. Bryan CF, Luger AM, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS. Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation. 2001 Apr 15; 71(7):875-9.
    View in: PubMed
    Score: 0.013
  10. Bryan CF, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Harrell KM, Helling TS, Luger AM. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype. Clin Transplant. 2001; 15 Suppl 6:28-35.
    View in: PubMed
    Score: 0.012
  11. Bryan CF, Shield CF, Pierce GE, Warady BA, Aeder MI, Martinez J, Luger AM, Nelson PW, Ross G, Muruve N, Mitchell SI. Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens. Clin Transplant. 2000 Feb; 14(1):79-84.
    View in: PubMed
    Score: 0.012
  12. Bryan CF, Shield CF, Warady BA, Aeder MI, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Muruve N, Thien ER. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):225-7.
    View in: PubMed
    Score: 0.011
  13. Bryan CF, Shield CF, Nelson PW, Pierce GE, Ross G, Luger AM, Warady BA, Helling TS, Aeder MI, Martinez J, Hughes TM, Beck ML, Harrell KM. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. Transplantation. 1998 Dec 27; 66(12):1714-7.
    View in: PubMed
    Score: 0.011
  14. Bryan CF, Baier KA, Nelson PW, Luger AM, Martinez J, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS, Muruve N. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation. 1998 Dec 27; 66(12):1827-32.
    View in: PubMed
    Score: 0.011
  15. Bryan CF, Mitchell SI, Lin HM, Nelson PW, Shield CF, Luger AM, Pierce GE, Ross G, Warady BA, Aeder MI, Helling TS, Landreneau MD, Harrell KM. Influence of the Rh (D) blood group system on graft survival in renal transplantation. Transplantation. 1998 Feb 27; 65(4):588-92.
    View in: PubMed
    Score: 0.010
  16. Bryan CF, Tegtmeier GE, Polito A, Bayer W, Pierce GE, Shield CF, Warady BA, Aeder MI, Borkon AM, Estep TH, Forster J, Landreneau MD, Luger AM, Nelson PW, Ross G. Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors. Transplant Proc. 1996 Feb; 28(1):155-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.